Evidence map›Paper›PMID 25467621›Full record

ArticleDiabetes research and clinical practice2015

Effects of restoring normoglycemia in type 1 diabetes on inflammatory profile and renal extracellular matrix structure after simultaneous pancreas and kidney transplantation.

Trine Marita Reine, Ingrid Benedicte Moss Kolseth, Astri Jeanette Meen, Jørn Petter Lindahl, Trond Geir Jenssen, Finn Per Reinholt, Joseph Zaia, Chun Shao, Anders Hartmann, Svein Olav Kolset

Open access · greenAbstract read
In one paragraph

Article in Diabetes research and clinical practice, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Proteomics, Glycomics, and Glycoproteomics of Matrisome Molecules.Molecular & cellular proteomics : MCP · 2019
    Review
  6. Protective effects of low-dose rapamycin combined with valsartan on podocytes of diabetic rats.International journal of clinical and experimental medicine · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Trine Marita ReineDepartment of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway. Electronic address: t.m.reine@medisin.uio.no.
Ingrid Benedicte Moss KolsethDepartment of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.
Astri Jeanette MeenDepartment of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.
Jørn Petter LindahlDepartment of Transplant Medicine, Section of Nephrology, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
Trond Geir JenssenDepartment of Transplant Medicine, Section of Nephrology, Oslo University Hospital, Rikshospitalet, Oslo, Norway; Institute of Clinical Medicine, Faculty of Health Science, University of Tromsø, Tromsø, Norway.
Finn Per ReinholtDepartment of Pathology, University of Oslo and Oslo University Hospital, Rikshospitalet, Oslo, Norway.
Joseph ZaiaDepartment of Biochemistry, Boston University School of Medicine, Boston University Medical Campus, Boston, MA, USA.
Chun ShaoDepartment of Biochemistry, Boston University School of Medicine, Boston University Medical Campus, Boston, MA, USA.
Anders HartmannDepartment of Transplant Medicine, Section of Nephrology, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
Svein Olav KolsetDepartment of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.
Oslo University Hospital · NOUniversity of Oslo · NOBoston University · US

Funding

Mass Spectrometry Resource for Biology and MedicineP41GM104603 · NIGMS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI COSTELLO, CATHERINE E. · 2012 to 2017
$10.4M
Post-biosynthetic Remodeling of Heparan SulfateR01HL098950 · NHLBI · BOSTON UNIVERSITY MEDICAL CAMPUS · PI ZAIA, JOSEPH · 2010 to 2013
$1.6M
NHLBI NIH HHS R01 HL098950NIGMS NIH HHS P41 GM104603
6 · The paper itself

Abstract

aimsPatients with type 1 diabetes and end-stage renal disease with simultaneous pancreas and kidney (SPK) or kidney transplants alone (KA) were recruited 9-12 years post transplantation. We investigated differences between these groups with regard to inflammatory parameters and long-term structural changes in kidneys.

methodsBlood samples were analyzed by ELISA and multiplex for chemokines, cytokines, growth factors, cell adhesion molecules and matrix metalloproteinases. Kidney graft biopsies were analyzed by electron microscopy for glomerular basement membrane thickness. Heparan- and chondroitin sulfate disaccharide structures were determined by size exclusion chromatography mass-spectrometry.

resultsThe SPK and the KA group had average glycated hemoglobin A1c (HbA1c) of 5.8% (40 mmol/mol) and 8.6% (70 mmol/mol) respectively. SPK recipients also had 16.2% lower body mass index (BMI) and 46.4% lower triglyceride levels compared with KA recipients, compatible with an improved metabolic profile in the SPK group. Plasminogen activator inhibitor (PAI-1), C-reactive protein (CRP) and vascular endothelial growth factor (VEGF) were lower in the SPK group. In kidney graft biopsies of the KA-patients an 81.2% increase in average glomerular basement membrane thickness was observed, accompanied by alterations in heparan sulfate proteoglycan structure. In addition to a decrease in 6-O-sulfated disaccharides, an increase in non-N-sulfated disaccharides with a corresponding slight decrease in N-sulfation was found in kidney biopsies from hyperglycemic patients.

conclusionsPatients with end stage renal disease subjected to KA transplantation showed impaired inflammatory profile, increased thickness of basement membranes and distinct changes in heparan sulfate structures compared with SPK recipients.

Indexed as

Kidney TransplantationPancreas TransplantationAdultCross-Sectional StudiesDiabetes Mellitus, Type 1FemaleHeparan SulfateHumansHyperglycemiaInflammationKidneyKidney Failure, ChronicMaleMiddle AgedProteoglycansHeparan SulfateProteoglycansDiabetesHeparan sulfateHyperglycemiaKidneyProteoglycans

Identifiers

PMID25467621
PMCPMC4324617
OpenAlexW2044150476

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.